RxDoctor Payments Data

Edwin Gravereaux, MD

Vascular Surgery · Boston, MANPI 1376500751

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $53,385 of the $61,042 with a category attached, or 87.5%. Maquet Cardiovascular L.L.C. accounts for 62.9% of it on its own, with 13 other manufacturers making up the rest. Reporting peaked in 2024 at $15,866 and has fallen 76.7% since, to $3,697 in 2025. Among vascular surgery clinicians in MA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$61,042in general payments, 2019–2025

Across 162 payments — averaging $376.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Maquet Cardiovascular L.L.C.$38K
  • Abbott$10K
  • Surmodics, Inc.$4K
  • Endologix LLC$4K
  • Penumbra, Inc.$1K
  • Shockwave Medical, Inc$797
  • plus $2K from 8 others

What the payments were for

  • Consulting fees$53,38587%
  • Travel & lodging$1,2022%
  • Food & beverage$6,45411%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$61,042 in reported general payments places this provider in the 90th percentile of 142 vascular surgery providers in Massachusetts.

See all vascular surgery providers in Massachusetts

Medicare billing

Part B allowed, 2024
$91,302
Medicare patients
368
Services billed
530

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other vascular surgery in Boston

See the full list for Massachusetts

Where these figures come from

Is this you, or does something look wrong? →